Access cutting-edge head and neck cancer treatment through this clinical trial at a research site in Gilbert. Study-provided care at no cost to qualified participants.
Access head and neck cancer specialists in Gilbert at no cost
This study follows strict safety protocols and ethical guidelines
All study-related head and neck cancer treatment provided free
The purpose of this study is to compare the efficacy and safety of ficlatuzumab plus cetuximab compared to placebo plus cetuximab in participants with recurrent/metastatic (R/M) HPV-negative Head and Neck Cancer. The primary hypothesis is that ficlatuzumab combined with cetuximab is superior to cetuximab alone in terms of progression-free survival and/or overall survival.
Sponsor: AVEO Pharmaceuticals, Inc.
Check if you qualify for this head and neck cancer clinical trial in Gilbert, AZ
If you're searching for head and neck cancer treatment options in Gilbert, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Gilbert research site is actively enrolling participants for this clinical trial. You'll receive care from experienced head and neck cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.